19.86

1.69% -0.34

Tandem Diabetes Care Inc (TNDM)

Overview News Price History Option Chain Financials Why TNDM Down? Discussions Forecast Stock Split

Tandem Diabetes Care Inc stock is traded at $19.86, with a volume of 469.14K. It is down -1.69% in the last 24 hours and down -11.15% over the past month. Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Previous Close:

$20.20

Open:

$20.22

24h Volume:

469.14K

Relative Volume:

0.26

Market Cap:

$1.35B

Revenue:

$796.00M

Net Income/Loss:

$-136.49M

P/E Ratio:

-9.5024

EPS:

-2.09

Net Cash Flow:

$-64.24M

1W Performance:

-3.08%

1M Performance:

-11.15%

6M Performance:

+24.97%

1Y Performance:

-45.70%

1-Day Range:

$19.75

$20.60

1-Week Range:

$19.75

$21.64

52-Week Range:

$9.98

$37.93

Tandem Diabetes Care Inc Stock (TNDM) Company Profile

Name

Tandem Diabetes Care Inc

Sector

Healthcare (1119)

Industry

Medical Devices (140)

Phone

858-366-6900

Address

12400 HIGH BLUFF DRIVE, San Diego, CA

Employee

2,650

Twitter

@tandemdiabetes

Next Earnings Date

2024-11-06

Latest SEC Filings

TNDM's Discussions on Twitter

Compare TNDM with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TNDM Tandem Diabetes Care Inc	19.86	1.37B	796.00M	-136.49M	-64.24M	-2.09
ABT Abbott Laboratories	107.11	189.14B	44.33B	6.48B	6.92B	3.7033
BSX Boston Scientific Corp	93.53	138.74B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	355.69	136.52B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	101.35	129.06B	34.76B	4.79B	5.21B	3.7017
EW Edwards Lifesciences Corp	83.77	48.90B	5.88B	1.34B	799.60M	2.3489

Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-16-25	Upgrade	Robert W. Baird	Neutral → Outperform
Oct-21-25	Resumed	Stifel	Hold
Sep-08-25	Initiated	Oppenheimer	Outperform
Aug-12-25	Upgrade	Citigroup	Sell → Neutral
Aug-07-25	Downgrade	Piper Sandler	Overweight → Neutral
Jul-09-25	Downgrade	Citigroup	Neutral → Sell
Jun-16-25	Initiated	Truist	Hold
Apr-10-25	Initiated	Mizuho	Neutral
Mar-05-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Mar-04-25	Downgrade	Citigroup	Buy → Neutral
Mar-03-25	Downgrade	Wells Fargo	Overweight → Equal Weight
Feb-28-25	Downgrade	Bernstein	Outperform → Mkt Perform
Dec-02-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-06-24	Initiated	Bernstein	Outperform
Oct-04-24	Initiated	Goldman	Neutral
Oct-02-24	Initiated	RBC Capital Mkts	Outperform
Aug-22-24	Initiated	Morgan Stanley	Equal-Weight
Aug-08-24	Initiated	Canaccord Genuity	Buy
May-30-24	Initiated	Redburn Atlantic	Buy
May-22-24	Upgrade	Citigroup	Neutral → Buy
Apr-29-24	Upgrade	Wells Fargo	Equal Weight → Overweight
Apr-25-24	Upgrade	Leerink Partners	Market Perform → Outperform
Mar-26-24	Upgrade	Stifel	Hold → Buy
Aug-04-23	Downgrade	Citigroup	Buy → Neutral
May-05-23	Downgrade	BofA Securities	Neutral → Underperform
Apr-24-23	Downgrade	Raymond James	Outperform → Mkt Perform
Mar-29-23	Initiated	UBS	Neutral
Jan-26-23	Initiated	Wolfe Research	Peer Perform
Nov-15-22	Upgrade	Wells Fargo	Underweight → Equal Weight
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Buy
Aug-09-22	Downgrade	Wells Fargo	Overweight → Underweight
Mar-02-22	Resumed	BofA Securities	Neutral
Jan-19-22	Upgrade	Wells Fargo	Equal Weight → Overweight
Jul-21-21	Resumed	Cowen	Outperform
May-25-21	Initiated	Barclays	Underweight
Dec-15-20	Downgrade	Wells Fargo	Overweight → Equal Weight
Aug-20-20	Initiated	Wells Fargo	Overweight
Jul-31-20	Upgrade	Guggenheim	Neutral → Buy
Jul-06-20	Upgrade	Citigroup	Neutral → Buy
Jun-18-20	Reiterated	Raymond James	Outperform
Apr-24-20	Downgrade	SVB Leerink	Outperform → Mkt Perform
Mar-23-20	Downgrade	Guggenheim	Buy → Neutral
Mar-05-20	Initiated	Citigroup	Neutral
Feb-06-20	Initiated	Raymond James	Outperform
Feb-04-20	Downgrade	Robert W. Baird	Outperform → Neutral
Oct-18-19	Initiated	Guggenheim	Buy
Oct-04-19	Upgrade	UBS	Neutral → Buy
May-17-19	Reiterated	BofA/Merrill	Neutral
May-13-19	Initiated	SVB Leerink	Outperform
Mar-08-19	Initiated	BMO Capital Markets	Outperform
Mar-05-19	Reiterated	BofA/Merrill	Neutral
Feb-27-19	Reiterated	Lake Street	Buy
Nov-21-18	Upgrade	Robert W. Baird	Neutral → Outperform
Sep-26-18	Reiterated	Dougherty & Company	Buy
Sep-26-18	Reiterated	Piper Jaffray	Overweight

View All

Tandem Diabetes Care Inc Stock (TNDM) Latest News

07:58 AM

Improved Growth Outlook and Better-Than-Expected Results Boosted Tandem Diabetes Care (TNDM) in Q4 - Insider Monkey

07:58 AM

Jan 26, 2026

TNDM Stock: TD Cowen Boosts Price Target and Reaffirms Buy Ratin - GuruFocus

Jan 26, 2026

Can Tandem Diabetes Care Inc stock double in the next yearInsider Selling & Weekly Setup with ROI Potential - baoquankhu1.vn

Jan 26, 2026

Jan 25, 2026

Discipline and Rules-Based Execution in TNDM Response - Stock Traders Daily

Jan 25, 2026

3 Reasons to Avoid TNDM and 1 Stock to Buy Instead - Finviz

Jan 25, 2026

Jan 22, 2026

How Device Correction and Securities Probe Will Impact Tandem Diabetes Care (TNDM) Investors - Sahm

Jan 22, 2026

Jan 21, 2026

Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - Barchart.com

Jan 21, 2026

Jan 20, 2026

TNDM Investor News: If You Have Suffered Losses in Tandem - GlobeNewswire

Jan 20, 2026

Aug Reactions: Will Tandem Diabetes Care Inc benefit from geopolitical trendsJuly 2025 Levels & Fast Gain Swing Alerts - baoquankhu1.vn

Jan 20, 2026

Jan 19, 2026

Does Tandem Diabetes Care Inc. (TD5A) stock trade below intrinsic value2025 Market Trends & Technical Pattern Recognition Alerts - bollywoodhelpline.com

Jan 19, 2026

Jan 18, 2026

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - TMX Newsfile

Jan 18, 2026

מידע למשקיעים ב-TNDM: אם סבלתם הפסדים בחברת Tandem Diabetes Care, Inc (נאסד"ק: TNDM), אתם מוזמנים ליצור קשר עם משרד רוזן עורכי דין בנוגע לזכויותיכם - GlobeNewswire Inc.

Jan 18, 2026

Jan 16, 2026

Diabetes warning issued over insulin pump error - MSN

Jan 16, 2026

A Look At Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Recovery - Sahm

Jan 16, 2026

Jan 15, 2026

Aug Ideas: Can Tandem Diabetes Care Inc continue delivering strong returnsDollar Strength & High Win Rate Trade Alerts - baoquankhu1.vn

Jan 15, 2026

Jan 14, 2026

Behavioral Patterns of TNDM and Institutional Flows - Stock Traders Daily

Jan 14, 2026

A Look At The Fair Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - 富途牛牛

Jan 14, 2026

Jan 13, 2026

Stock Analysis: How Tandem Diabetes Care Inc stock responds to policy changesDip Buying & Daily Entry Point Alerts - Bộ Nội Vụ

Jan 13, 2026